Ensol Biosciences Inc. - Product Pipeline Review

Global Markets Direct’s, ‘Ensol Biosciences Inc. - Product Pipeline Review - 2016’, provides an overview of the Ensol Biosciences Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Ensol Biosciences Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Ensol Biosciences Inc.

The report provides overview of Ensol Biosciences Inc. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Ensol Biosciences Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Ensol Biosciences Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Ensol Biosciences Inc.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Ensol Biosciences Inc.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Ensol Biosciences Inc.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Ensol Biosciences Inc. Snapshot 5

Ensol Biosciences Inc. Overview 5 ...

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Ensol Biosciences Inc. Snapshot 5

Ensol Biosciences Inc. Overview 5

Key Information 5

Key Facts 5

Ensol Biosciences Inc. - Research and Development Overview 6

Key Therapeutic Areas 6

Ensol Biosciences Inc. - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Pipeline Products - Out-Licensed Products 10

Out-Licensed Products/Combination Treatment Modalities 11

Ensol Biosciences Inc. - Pipeline Products Glance 12

Ensol Biosciences Inc. - Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

Discovery Products/Combination Treatment Modalities 13

Ensol Biosciences Inc. - Drug Profiles 14

Charis-1000 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

Hesed-1000 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

Peniel-5000 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

Amos-1000 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Ephphatha-1000 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Hesed-2000 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

Hesed-3000 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Hesed-4000 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Hesed-5000 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Moriah-1000 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Shiloah-1000 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Ensol Biosciences Inc. - Pipeline Analysis 25

Ensol Biosciences Inc. - Pipeline Products by Molecule Type 25

Ensol Biosciences Inc. - Recent Pipeline Updates 26

Ensol Biosciences Inc. - Dormant Projects 27

Ensol Biosciences Inc. - Locations and Subsidiaries 28

Head Office 28

Appendix 29

Methodology 29

Coverage 29

Secondary Research 29

Primary Research 29

Expert Panel Validation 29

Contact Us 29

Disclaimer 30

List of Tables

List of Tables

Ensol Biosciences Inc., Key Information 5

Ensol Biosciences Inc., Key Facts 5

Ensol Biosciences Inc. - Pipeline by Indication, 2016 7

Ensol ...

List of Tables

Ensol Biosciences Inc., Key Information 5

Ensol Biosciences Inc., Key Facts 5

Ensol Biosciences Inc. - Pipeline by Indication, 2016 7

Ensol Biosciences Inc. - Pipeline by Stage of Development, 2016 8

Ensol Biosciences Inc. - Monotherapy Products in Pipeline, 2016 9

Ensol Biosciences Inc. - Out-Licensed Products in Pipeline, 2016 10

Ensol Biosciences Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016 11

Ensol Biosciences Inc. - Preclinical, 2016 12

Ensol Biosciences Inc. - Discovery, 2016 13

Ensol Biosciences Inc. - Pipeline by Molecule Type, 2016 25

Ensol Biosciences Inc. - Recent Pipeline Updates, 2016 26

Ensol Biosciences Inc. - Dormant Developmental Projects,2016 27

List of Figures

List of Figures

Ensol Biosciences Inc. - Pipeline by Top 10 Indication, 2016 7

Ensol Biosciences Inc. - Pipeline by Stage of Development, 2016 8 ...

List of Figures

Ensol Biosciences Inc. - Pipeline by Top 10 Indication, 2016 7

Ensol Biosciences Inc. - Pipeline by Stage of Development, 2016 8

Ensol Biosciences Inc. - Monotherapy Products in Pipeline, 2016 9

Ensol Biosciences Inc. - Out-Licensed Products in Pipeline, 2016 10

Ensol Biosciences Inc. - Pipeline by Molecule Type, 2016 25

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports